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Abstract
Background: Bacterial vaginosis (BV) has been most consistently linked to sexual behaviour, and the
epidemiological profile of BV mirrors that of established sexually transmitted infections (STIs). It remains a matter of
debate however whether BV pathogenesis does actually involve sexual transmission of pathogenic microorganisms from men to women. We therefore made a critical appraisal of the literature on BV in relation to sexual
behaviour.
Discussion: G. vaginalis carriage and BV occurs rarely with children, but has been observed among adolescent,
even sexually non-experienced girls, contradicting that sexual transmission is a necessary prerequisite to disease
acquisition. G. vaginalis carriage is enhanced by penetrative sexual contact but also by non-penetrative digitogenital contact and oral sex, again indicating that sex per se, but not necessarily coital transmission is involved.
Several observations also point at female-to-male rather than at male-to-female transmission of G. vaginalis,
presumably explaining the high concordance rates of G. vaginalis carriage among couples. Male antibiotic
treatment has not been found to protect against BV, condom use is slightly protective, whereas male circumcision
might protect against BV. BV is also common among women-who-have-sex-with-women and this relates at least in
part to non-coital sexual behaviours. Though male-to-female transmission cannot be ruled out, overall there is little
evidence that BV acts as an STD. Rather, we suggest BV may be considered a sexually enhanced disease (SED), with
frequency of intercourse being a critical factor. This may relate to two distinct pathogenetic mechanisms: (1) in
case of unprotected intercourse alkalinisation of the vaginal niche enhances a shift from lactobacilli-dominated
microflora to a BV-like type of microflora and (2) in case of unprotected and protected intercourse mechanical
transfer of perineal enteric bacteria is enhanced by coitus. A similar mechanism of mechanical transfer may explain
the consistent link between non-coital sexual acts and BV. Similar observations supporting the SED pathogenetic
model have been made for vaginal candidiasis and for urinary tract infection.
Summary: Though male-to-female transmission cannot be ruled out, overall there is incomplete evidence that BV
acts as an STI. We believe however that BV may be considered a sexually enhanced disease, with frequency of
intercourse being a critical factor.

Background
Bacterial vaginosis: a brief introduction

Bacterial vaginosis (BV) is a condition characterised by
the partial loss of the indigenous vaginal lactobacilli on
the one hand, and polymicrobial anaerobic overgrowth
of the vaginal mucosa on the other hand [1]. Although
BV remains often asymptomatic, it still is, along with
vulvovaginal candidiasis, the most common cause of
vaginitis, and hence among the commonest reasons for
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women to seek medical help [2]. In recent years BV has
further emerged as a global issue of concern due to its
association with ascending genital tract infection and
with sexually transmitted infections [3]. Infections
related to BV may broadly be categorized as opportunistic infections with BV-associated bacteria and as infections due to sexually transmitted agents. In the first
category, ascending genital tract infection with BVrelated pathogens has been associated with postabortion
[4] and postpartum endometritis [5], pelvic inflammatory disease (PID) [6,7], and, during pregnancy, late foetal loss and spontaneous preterm birth [8,9]. In the
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second category, BV renders women particularly vulnerable to the acquisition of Trichomonas vaginalis, Neisseria gonorrhoeae [10,11], Chlamydia trachomatis [11],
HSV-2 [12] and HIV-1 [13-15]. Moreover, it has been
documented that bacterial vaginosis propagates viral
replication and vaginal shedding of the HIV-1 [16-18]
and HSV-2 [19] viruses, thereby further enhancing the
spread of these viruses.
Failure to control the high prevalence of BV has therefore now become a global issue of concern. As standard
treatment with antibiotics tends to be ineffective in the
long run [20], more efforts may be directed to preventive measures to reduce the incidence of BV. In particular, among the most prominent risk factors, sexual
behaviour and vaginal douching are modifiable risk factors, e.g. a recent douching cessation trial documented a
significant reduction in BV incidence following a douching cessation intervention [21]. Sex education may also
add to the prevention of BV, provided that we have sufficient knowledge as to how sexual behaviour exactly
enhances BV acquisition. Understanding the contribution of sexual activity to BV pathogenesis is therefore
integral to improve the management and prevention of
BV and to reduce its associated complications.
Bacterial vaginosis and sexual behaviour

Of all risk factors explored thus far, sexual behaviourrelated characteristics have been most consistently associated with BV. This extensive body of literature is at
first sight not entirely consistent however, as BV has
been associated with a variety of sexual behaviourrelated characteristics including young age at coitarche,
life time number of sex partners, a recent history of
multiple sex partners, and a recent history of a new sex
partner. These inconsistencies make it difficult to define
what genuinely represents high-risk sexual behaviour to
the acquisition of BV. Possibly, different studies may
have been better designed to identify certain epidemiological measures than others, while the aforementioned
measures of sexual behaviour may also be interdependent. Moreover, some risk factors identified may be
proxy variables to the true risk exposure, e.g. a new sex
partner might be predictive to frequency of intercourse.
If anything, the aforementioned risk factors all seem to
point somehow at a consistent association between level
of sexual activity and the odds of acquiring of BV. It
remains a matter of debate however whether BV pathogenesis does actually involve sexual transmission of
pathogenic micro-organisms from men to women [22].
We therefore sought to review the literature on BV
epidemiology in relation to sexual behaviour thereby
emphasizing on those data that could provide insight
into the disease mechanisms in relation to sexual behaviour. In particular, we reviewed the data on the
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transmissibility of BV and the indications pro an contra
transmission of BV from male to female, from female to
male, from female to female, and further addressed the
association between non-coital sexual behaviours in
relation to BV and the occurrence of BV in sexually
inexperienced women.
It may be acknowledged that the literature on BV epidemiology has largely focused on the presence of G.
vaginalis, which is a key pathogen to BV, also numerically dominant in the biofilm mode of overgrowth in
BV, but not necessarily the BV initiating or causative
agent. Throughout this review we also discuss these
data on G. vaginalis, though we recognize that the patterns of sexual transmission for G. vaginalis may not be
the same as those for BV.

Discussion
Observations on the transmissibility of bv

Early experiments conducted in the 1950s and 1960s are
the only studies thus far that addressed the transmissibility of BV in a direct manner. In particular, Gardner
and Dukes [23] accomplished to induce BV in 11 of 15
female volunteers who were inoculated directly with
vaginal secretions from patients with BV. Conversely,
when they inoculated women with pure culture Gardnerella vaginalis, BV occurred in only one in 13 volunteering women. However, Criswell et al [24], did
manage to induce BV in 7 out of 29 volunteering
women when using higher inocula of pure culture Gardnerella. Hence, in these early experiments, the transmissible nature of BV had been clearly demonstrated.
The contention of BV as a transmissible disease then
gained even more significance as epidemiological data
pointed at concurrent carriage of G. vaginalis by women
with BV and their male partners. Gardner and Dukes
isolated G. vaginalis from the urethra in 45 of 47 male
partners of women with BV and later on, Pheifer et al
detected G. vaginalis in the urethra of 27 of 34 partners
of BV patients [23,25]. Most recently, Swidsinski et al
assessed G. vaginalis carriage in a large cross-sectional
study [26] involving different population groups. Building further on the discovery of the BV biofilm [27,28],
Swidsinski et al first described that the presence of G.
vaginalis can also reliably be assessed through fluorescence-in-situ-hybridisation (FISH) analysis on desquamated epithelial cells in urine in both women and men.
In this study, the presence of G. vaginalis was further
referred to as “dispersed” Gardnerella, consisting of
loosely dispersed Gardnerella cells, and as “cohesive”
Gardnerella, consisting of clustered Gardnerella cells
adhesive to the epithelium, the latter indicative of the
presence of the Gardnerella biofilm, previously shown
an obligate finding in BV [27]. The authors enrolled
among others, 20 women with symptomatic BV and 10
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of their partners and 72 consecutive married pregnant
women and their 72 partners. It was shown that the 20
women with symptomatic BV consistently presented
with cohesive Gardnerella as did the 10 partners investigated. Among the 72 married pregnant women and their
72 partners, dispersed Gardnerella was found in 14%
and cohesive Gardnerella in 17% of the females. Again,
cohesive Gardnerella was consistently found among the
partners of the women with cohesive Gardnerella, for
whom the samples were analysable. No such concordance was observed for dispersed Gardnerella. Hence,
the previously known strong concordance of G. vaginalis carriage by both partners when a woman has BV was
herewith confirmed but further refined by the almost
absolute concordance of cohesive Gardnerella carriage,
which might indicate that this biofilm mode of growth
represents the infectious mode of Gardnerella and/
or BV.
Following the demonstration of transmissibility of G.
vaginalis isolated from pure culture, the recognition of
male carriage, and the concordance of G. vaginalis carriage between couples, Piot et al provided further evidence of sexual transmission by obtaining vaginal
cultures from 12 women with BV and urethral cultures
from their 12 male consorts within 24 hours [29]. The
G. vaginalis biotypes isolated from both partners were
the same for 11 of the couples (p = 0.005), strongly suggestive for sexual transmission of G. vaginalis.
Observations that support male-to-female heterosexual
transmission

Since male G. vaginalis carriage was first demonstrated,
as mentioned above, among male partners of patients
with BV, it has long been postulated that male carriage
might indicate the presence of a male reservoir possibly
leading to male-to-female transmission, although this
assumption is not unequivocally supported by the literature. We herewith review the data on male carriage of
G. vaginalis and on measures directed towards prevention of male-to-female transmission, including partner
treatment with antibiotics, condom use and male
circumcision.
The two largest cohort studies on male carriage of G.
vaginalis conducted until present - both involving male
attendees of a sexually transmitted disease clinic - documented male urethral carriage of G. vaginalis at a rate
of 11.4% (49/430) in the UK [30] and of 4.5% (10/309)
in Sweden [31]. As a matter of fact, male carriage of G.
vaginalis may even be higher than estimated from the
aforementioned studies, as urethral sampling may not
be the optimal approach to document it. Kinghorn et al
found a significantly higher rate of G. vaginalis isolation
from preputial than from urethral swabs [32]. Swidsinski
et al recently made a similar observation, and found
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that desquamated epithelial cells loaded with G. vaginalis could only reliably be recovered in a urine specimen
if the praeputium was not pulled back during voiding
[26]. In this manner, it was shown that among 100 men
admitted to a department of internal medicine, dispersed Gardnerella occurred in 4% of males, while cohesive Gardnerella was present in 7% [26]. In addition,
several culture-based studies have also documented the
presence of G. vaginalis in semen samples [33-38] - possibly pointing at a seminal or prostatic reservoir whereby in one study G. vaginalis was recovered from
semen in as much as 38% of 58 men attending an infertility clinic [34]. Intriguingly, preceding the renowned
description of G. vaginalis as the causative agent in
non-specific vaginitis by Gardner and Dukes [23], the
very first description of the species now known as G.
vaginalis was in association with prostatitis [39].
Up to date, six randomized controlled trials [40-45]
have addressed the effectiveness of male partner treatment in the treatment of BV. Five out of the six studies
failed to document any benefit from male partner treatment with antibiotics [40-42,44,45]. It may be acknowledged here, that most of these studies suffer from
multiple methodological shortcomings [46] including
small sample sizes and large drop out rates. Moreover,
the antibiotic regimens applied to male partners of
women diagnosed with BV are mostly single doses or
short courses with metronidazole or tinidazole, i.e. treatments that have been documented to be also poorly
effective in women with BV and that are therefore not
recommended by the CDC [47]. In only one of the six
RCTs, a CDC-recommended regimen for women was
administered to the spouses of women with BV, consisting of a 7-day course of oral clindamycin [45], though
again without any noticeable effect. Finally, what one
really wants to know is whether male treatment might
prevent the recurrence of BV among their female partners, presuming that women might get re-infected from
a male reservoir. This was addressed in two studies with
a 3 month follow-up [42,45] whereby a recurrence rate
of at least 50% among women is expected [48]. Both
these studies [42,45] failed to document any benefit of
male sexual partner treatment on 3 month cure rates
among their female partners.
It may be concluded that the evidence suggests that
there is no benefit, i.e. reduction of BV occurrence in
women, by treating the sexual partners of women with
BV with the drug regimens tested [46]. It may further
be acknowledged that, when assuming a male-to-female
route of transmission, the true effect of male treatment
on the incidence of BV might at best be evaluated in a
study in which male carriers would be treated prophylactically. Also, direct assessment of efficacy of antibiotic
treatment for eradication of G. vaginalis and other
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BV-associated micro-organisms in male partners would
be essential, as the lack of effect of male treatment on
recurrence of BV in female partners not necessarily
excludes male-to-female reinfection, since male treatment may not eradicate biofilm-associated G. vaginalis.
With regard to condom use as a means of preventing
BV, six cross-sectional studies [49-54] yielded contradicting results. Longitudinal and cohort studies on the
other hand are more in line with each other towards a
beneficial effect of condom use vis-à-vis BV acquisition
[55-58], although the overall observed effect tends to be
rather limited with an average relative risk reduction
associated with condom use estimated at merely 20% in
a recent meta-analysis [59]. The two most recent studies
also addressed recurrent BV [58,60]. Hutchinson et al
found a very strong overall protective effect of consistent condom use on the occurrence of both incident
and recurrent BV in a three-year follow-up study
(adjusted odds ratio 0.37, 95% CI 0.20-0.70) [58]. Yotebieng et al on the other hand found that consistent condom use in a 6-month follow-up study was protective
against incident BV, but not against recurrent BV [60].
Hence, the evidence on consistent condom use as a protective means for BV, overall, seems to suggest a rather
moderate effect in the prevention of BV.
If the preputial space is suspected to act as the male
reservoir of BV-associated micro-organisms - as was
first suggested by Kinghorn et al [32] and recently reinforced by the findings by Swidsinski et al [26], who
found more G. vaginalis in men voiding without retracting the praeputium, then male circumcision is expected
to have a protective effect on the occurrence of BV.
However, results from a limited number of studies are
contradictive again. In a US retrospective case-control
study no difference was found in the prevalence of BV
between women with circumcised partners compared to
those with uncircumcised partners [61]. In a large, very
well-designed, randomised controlled trial involving a
large cohort of young men in Rakai, Uganda however,
male circumcision was associated with a significantly
decreased risk (adjusted prevalence risk ratio 0.60, 95%
CI 0.38-0.94) of BV at one year follow-up [62].
Observations that support female-to-male heterosexual
transmission

One of the earliest observations casting doubt over the
purportedly male-to-female sexual transmission route
comes from a large cohort study on urethral carriage of
G. vaginalis among men [30]. In this study, Dawson et
al isolated G. vaginalis from 11.4% of urethral samples
from 430 consecutive male patients attending a clinic
for sexually transmitted disease [30]. Interestingly, the
authors documented that the recovery rate of urethral
G. vaginalis was significantly higher in heterosexual
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men (14.5%) than among homosexual men (4.5%) (p <
0.001). This finding suggests that, somehow, heterosexual contact enhances male carriage of G. vaginalis, as if
female-to-male transmission rather than the opposite
route is at stake. Ten years later, Holst conducted an
elegant experiment that corroborates this hypothesis
[63]. Holst first documented that several BV-associated
organisms, including Mobiluncus mulieris, M. curtisii
and G. vaginalis, could be isolated from the urethras
and/or coronal sulci of 10 in 44 male consorts (22.7%)
of women with BV. However, after two weeks of consistent condom use during regular sexual intercourse,
these BV index species disappeared from all men [63],
suggesting that transient carriage of BV-associated
micro-organisms by men actually may ensue from (continued) female-to-male contamination during intercourse. A very recent study by Schwebke et al [64]
corroborates this. In this study, Schwebke et al [64]
investigated male carriage of G. vaginalis through species-specific PCR in urine, on a urethral swab, and on a
swab obtained from the coronal sulcus from 47 men, of
whom 23 were partners of women with BV and 24 were
partners of women without BV. Overall, G. vaginalis
was detected in 12 males. The authors observed that the
11 participants who did use a condom at the last sexual
encounter were all negative for G. vaginalis, whereas
one in three men (12/36) who did not use a condom at
the last sexual encounter was positive for Gardnerella.
Moreover, none of the 5 participants who stated that
they always used a condom for the past 3 months had
G. vaginalis, whereas 12/42 of those who did not always
use a condom in the past 3 months were positive for G.
vaginalis [64]. Thus, Schwebke et al found that G. vaginalis carriage by men is closely linked to condom use,
and hence this is suggestive for a female-to-male transmission-like route of infection, as had been suggested by
Holst [63] two decades ago.
These findings may at least in part explain the high
concordance rates between women with BV and their
male consorts as mentioned above and may further
explain the low success rate of BV eradication in
women by condom use by their partners [59].
In addition, a female-to-male route of transmission
may further be consistent with the observation that G.
vaginalis is not present in prepubertal boys, as apparent
from one study involving 99 boys with negative cultures
for G. vaginalis from the urethra, glans, and rectum
[65]. In accordance, in a study comprising 50 adolescent
males who had not engaged yet in sexual activity/who
were sexually inexperienced, G. vaginalis was isolated
from the urethra in only one [66] and in a study by the
same authors, involving 50 recently married, young men
in monogamous relationships with no history of STDs,
G. vaginalis was isolated from none of them [66].
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Observations on bacterial vagiginosis resulting from
non-coital sexual acts in heterosexuals

Among heterosexual women, non-coital sexual behaviours, including receptive oral sex, receptive anal sex,
and non-penetrative digito-genital contact have also
been identified to confer an increased risk of BV
acquisition.
Nandwani et al and Tchamouroff and Panja reported
on a prospective cohort study, including 256 heterosexual female patients, attending a genito-urinary
medicine clinic, and found a highly significant difference in the rate of BV among women who reported
receptive oral sex in the previous four weeks (41/111
or 37%) as compared to women who did not experience cunnilingus in the past four weeks (14/145 or
10%, p < 0.001) [67,68]. Schwebke et al also found that
an unstable microflora - as defined by the number of
episodes of vaginal microflora shifting away from a
Lactobacillus-dominated microbiota to a bacterial
vaginosis-like profile - was significantly associated with
more frequent episodes of receptive oral sex [69].
Interestingly, a similar observation has been repeatedly
made with regard to cunnilingus and vaginal Candida
infection [70,71,54] and this was not explained by
differences in extragenital carriage of Candida by the
women nor by differences in extragenital and genital
carriage of Candida by their partners [70].
Unprotected receptive anal sex [72,73] and unprotected receptive anal sex before vaginal intercourse [74]
have also been associated with BV.
In a study involving 44 self-reported virginal women,
of which 27 provided detailed information regarding
sexual practices by a self-administered questionnaire,
self-collected tampons were tested for G. vaginalis and
A. vaginae through species-specific PCRs [75]. Surprisingly, it was found that G. vaginalis carriage in these virginal women was very strongly associated with oral sex
and non-penetrative digito-genital contact [75]. Similarly, Fethers et al very recently documented an association among 17-21-year-old females between noncoital
sexual practices (oral sex and non-penetrative digitogenital contact) and the occurrence of BV [76].
Similarly, recurrent vaginal candidiasis has also been
associated with a history of recent masturbating with
saliva by both the patient as her partner, while this was
not explained by oral Candida carriage [70]. Recurrent
urinary tract infection has also been associated with frequent masturbation [77].
Observations on the occurrence of bacterial vaginosis in
sexually inexperienced women

Clearly, there is ample evidence that BV is not confined
to women who are or were ever engaged in a heterosexual relationship, much in contrast to traditional STDs,
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indicating that heterosexual penetrative contact is
definitely not a necessary prerequisite to the acquisition
of BV.
Swidsinski et al investigated G. vaginalis carriage in 50
premenarchal girls and found that, dispersed Gardnerella occurred in 10%, whereas none of the 50 girls
showed cohesive, i.e. biofilm-associated, Gardnerella
[26]. It has to be acknowledged here, that higher prevalence rates of G. vaginalis have been found in sexually
abused girls as compared to non-abused girls in most
[78-80] though not all studies [81]. Apart from G. vaginalis carriage, bacterial vaginosis in children is however
rare. Anecdotically, Papanikolaou et al reported one
case of recurrent BV in a 17-year old adolescent with an
intact hymen [82].
In contrast, once beyond the menarche, BV also
occurs among sexually inexperienced adolescents and
virginal women according to several studies [83-85],
albeit at lower rates on average as compared to sexually active reproductive aged-women. This contention
was recently challenged however by an Australian
study comprising 528 young women of which 25
women had BV [76] The largest sample up to date
involved US women, entering the military, with a
mean age of 19.1 years. In this study, BV in women
reporting to never have had vaginal intercourse
occurred at a rate of 18%, whereas their sexually
experienced counterparts had BV at a rate of 28% [84].
The findings on BV prevalence in the large cohort of
US women entering the military are in line with those
on G. vaginalis epidemiology with a limited number of
studies also documenting higher rates of G. vaginalis
carriage among sexually active adolescents. Shafer et al
reported that up to one third of non-sexually active
adolescents harboured G. vaginalis, which was significantly less than in sexually active adolescents (60%)
[86]. Another culture-based study of 120 asymptomatic
14- to 17-year-old females found a twofold lower prevalence of G. vaginalis (17%) in women who reported
no penetrative sexual activity compared with sexually
active females (34%), albeit a non-statistically significant difference [87]. So, overall, several lines of evidence corroborate that the BV incidence is increased
by sexual activity, but clearly also contradict exclusive
heterosexual transmission.
Observations that support female-to-female transmission

Women with lesbian orientation or generally womenwho-have-sex-with-women (WSW) not only present
rather consistently with very high rates of BV, but
monogamous lesbian couples also present with almost
absolute concordance rates of vaginal microflora characteristics in terms of presence of lactobacilli in general
and of hydrogen peroxide-producing lactobacilli in
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particular, in terms of presence of BV -associated organisms [88]. These observations strongly suggest femaleto-female between-partner transmission of BV. These
observations may indicate strong between partner transmission or may just as well point to the higher occurrence among lesbian women of certain BV-enhancing
sexual practices (see below). Indeed, lesbian women have
been shown to be generally monogamous, to have low
promiscuity and to have an overall low incidence of
STDs [89]. Although many lesbian women do have a
history of heterosexual contact, this has not been an
explanatory factor to the occurrence of BV [89]. Among
the common exposures investigated thus far, the very
strong association between same gender sex and BV is
apparently not explained by confounders such as douching, though to some extent by higher rates of smoking
[89-91]. As to sexual behaviour-related characteristics
among WSW, an increased frequency of sexual activity
does not seem to be associated with the prevalence of
BV whereas several studies found an association with
increasing numbers of lifetime sexual female partners
[89-91], similar to what is observed with heterosexual
women. From a very detailed analysis including a number of self-reported sexual acts however, Marrazzo et al
retained significant associations between BV risk among
lesbians with a lack to always clean an insertive sex toy
before use, with oral-anal sex, and with recent genitalgenital contact with a female partner [88]. Albeit based
on a small series of patients, Tchamouroff and Panja
also suggested a link between receptive oral sex and BV
among WSW [68].
Comment

We reviewed the literature on BV epidemiology and
extracted published data on BV in relation to sexual
behaviour and thereby covered published studies and
congress proceedings going back for more than half a
century. We did not accomplish to unravel BV epidemiology, or to present a definite understanding of disease acquisition. A potential pitfall to our review, is that
a considerable number of data reviewed relate to a single pathogen, in particular G. vaginalis, involved in a
polymicrobial overgrowth condition. Though G. vaginalis is a key pathogen to BV, also numerically dominant
in the biofilm mode of overgrowth in BV, it is not
necessarily the BV initiating or causative agent.
Nonetheless, several conclusions, even if partially supported by circumstantial evidence, can be put forward.
First of all, it is clear that BV differs from established
STDs in as much that BV is not confined to women
who are, or were, ever engaged in a heterosexual relationship, indicating that, if anything, heterosexual penetrative contact is definitely not a necessary prerequisite
to the acquisition of BV.
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Among children and prepubertal girls, BV is rather
rare, except in case of sexual abuse, even though vaginal
carriage of G. vaginalis identified through FISH is not
uncommon in young girls according to one recent study
[26]. Similarly, based on culture-dependent study, G.
vaginalis seems to be virtually absent in prepubertal
boys.
Once beyond the menarche however, BV is observed
even among adolescent girls and sexually inexperienced
girls, and young women in general, at an appreciable
frequency, though on average at significantly lower rates
as compared to sexually active adolescents and young
women These findings do actually correlate well on
what has been observed on the epidemiology of G. vaginalis carriage among sexually active versus non-sexually
active adolescents [86,87].
Girls and young women who have never engaged in
penetrative sexual contact are likely to have practised
non-penetrative heterosexual behaviours however, and
Tabrizi et al documented that among virginal women G.
vaginalis carriage was very strongly associated with oral
sex and non-penetrative digito-genital contact [75].
Similarly, Fethers et al very recently documented an
association among 17-21-year-old females between noncoital sexual practices (oral sex and non-penetrative
digito-genital contact) and the occurrence of BV [76].
These studies are further in line with several other
studies that have identified oral receptive sex as a risk
factor for BV [67-69]. An obvious critique would be that
these studies suffer from confounding, however
Schwebke et al for instance performed a thorough multivariable analysis, thereby controlling for a number of
factors, and found that only receptive oral sex retained
significance as a risk factor to unstable vaginal microflora, indicating microflora shifting away from Lactobacillus dominance to a BV-like profile [69].
So overall, epidemiological data obtained from adolescent girls and young women, point at an alternative
pathogenesis model, not observed with traditionally
defined STDs, this is, while the evidence corroborates
on the one hand the sexual nature of BV, it clearly also
contradicts at least to some extent a traditional infectious disease-like route of disease acquisition.
Furthermore, there is convincing evidence ensuing
from condom studies [63,64], from studies among heterosexual versus homosexual men [30], and from studies
among young, monogamous men [65,66], that transmission of BV-associated micro-organisms may occur, however that female-to-male transmission may be a far
more common route than male-to-female transmission.
This sheds a completely different light on the high concordance rates of G. vaginalis carriage among couples of
whom the female partner has BV, which has been a
longstanding argument in favour of BV as an STD.
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Data on BV epidemiology among WSW in turn support both aforementioned pathogenetic pathways, i.e.
the high rates of BV among WSW may point either at
female-to-female route of transmission, either at sexual
enhancement of BV occurrence through non-coital sexual behaviours, similar to what is observed among heterosexual couples. Indeed, it has been observed that
WSW not only present rather consistently with very
high prevalence rates of G. vaginalis and bacterial vaginosis, but also that monogamous lesbian couples present
with high concordance rates of vaginal microflora characteristics in general. This was recently confirmed by
Marrazzo et al in terms of concordance between Lactobacillus species shared by monogamous lesbian couples
[92]. It remains elusive how this concordance is established, though likely to be sexually related. Marrazzo et
al thereby also pointed at a putative disease mechanism.
In particular, recent receptive digital-vaginal sex apparently affected the vaginal Lactobacillus community composition and specifically, receptive digital-vaginal sex
was associated with the presence of L. gasseri, whereas
the presence of L. gasseri in turn was associated with an
increased BV risk [92]. The presence of L. gasseri (and
L. iners) was recently also found among heterosexual
pregnant women to confer an increased BV risk [93].
So as a first set of conclusions, it appears as if (1)
women with BV may transmit BV-associated microorganisms to their male or female sexual partners and
(2) that non-coital sexual behaviours may enhance the
occurrence of BV, which may relate to an effect of such
non-penetrative heterosexual and homosexual behaviours on the Lactobacillus composition of the vaginal
niche, or by the introduction of G. vaginalis and/or
other BV-related anaerobes in the vagina, or by both.
Finally, while there is ample evidence that both protected and unprotected penetrative sexual behaviour is
at the very least a risk marker if not a causal factor to
BV, it remains to be answered for how sexual contact is
related to BV occurrence and whether this involves sexual transmission of BV-related micro-organisms from a
male to a female host. Two alternative explanations
emerge from the literature however.
Firstly, an interesting observation was published in
1971 by Leppäluoto [94]. Leppäluoto concluded - based
on the study of a large series of Papanicolaou smears
taken before and after unprotected coitus - that, lactobacilli-dominated precoital smears were replaced by G.
vaginalis dominant microflora in postcoital smears [94].
Hence, coitus seems to be associated with a temporary
disbalance in the delicate vaginal microflora equilibrium
in favour of BV-related micro-organisms. Leppäluoto
further launched the idea that the temporary imbalance
of the vaginal microflora towards a BV-like profile
serves sperm survival and transport, and further
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speculated that this imbalance is actually physiological
in nature, if the microflora is allowed enough time to
recover following a coital act [94]. This in turn might
concur with the observation made by Vallor et al, that
loss of hydrogen peroxide producing lactobacilli is primarily explained by the frequency of intercourse [95],
while a lack or loss of hydrogen peroxide producing lactobacilli is a strong risk factor to the occurrence of BV
[55,96-99].
The most straightforward explanation to this coital
effect on the vaginal microflora is that unprotected sexual intercourse alters the physico-chemical vaginal
environment thereby also affecting the vaginal microflora. In particular, it has been shown that the alkaline
prostatic content of the ejaculate raises the vaginal pH,
which remains elevated up to eight hours following coitus [100]. The alkaline ejaculate neutralizes the vaginal
pH and the reacidificiation rate of the vagina is estimated (based on in vitro experiments) to proceed at
about 0.75 pH units per hour in the presence of log8
lactobacilli [101]. Anaerobes grow preferably at a higher
pH. The optimum pH for G. vaginalis is 6 to 6.5 [102]
and it is 5 for P. bivia [103]. Hence, unprotected coitus
most likely induces an imbalance at the level of the vaginal growth conditions and epithelial binding sites in
favour of BV-associated micro-organisms as consistently
shown in a large series of postcoital smears by Leppäluoto [94]. Hence, increased coital activity may be one
of the reasons why lactobacilli are losing the plot [104].
However, if this were the only mechanism involved
than condom use would be expected to act as a very
effective means of prevention - which it is not - and
hence the proposed mechanism involving a pH-increase
does not quite explain why BV acquisition is almost
equally enhanced by protected intercourse, as outlined
above. Possibly, condom use might be protective against
incident BV, but this effect may be obscured in epidemiological studies due to recurrent BV in a substantial
number of women, not prevented by condom use.
As a second alternative mechanism, apart from the
coital pH-mediated effect on the vaginal microflora,
another conceivable mechanism that may be considered
is that vaginal penetration somehow promotes the transfer of perianal, perineal, and perivulvar bacteria to the
vagina, thereby possibly inducing BV in some women. A
similar mechanism has been observed for urinary tract
infections in women, and in particular, a significantly
elevated risk for urinary tract infection with E. coli associated with condom use has been observed [105], presumably involving a rectal-vestibular-urethral pathway.
A most important piece of evidence to this postulate
with regard to BV, comes from a study by Eschenbach
et al in which they aimed to document the effects of a
single episode of intercourse on the vaginal microflora
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in subjects randomly assigned to groups that used no
condom or lubricated (nonspermicide) condoms [106].
It was found that the 22 subjects who used no condoms
had significantly more E. coli at a high concentration
(> 10 5 cfu/mL) in the vagina following unprotected
intercourse. However, among the 20 subjects who did
use condoms there was also a marginally significant
trend towards more vaginal E. coli (p = 0.06) and a
highly significant increase in other enteric gram-negative
rods (p = 0.001) after protected intercourse [106]. It is
therefore conceivable that also other, non-coital sexual
acts such as oral sex endanger the vaginal microflora
through the transfer of BV-associated bacteria from the
rectal and perineal regions to the vulvar region and the
vagina in analogy to what has been observed for urinary
tract infections [107].
Taken together, the abovementioned data suggest that
unprotected intercourse may affect the vaginal microflora status through a suppressive effect on lactobacillary
colonisation, on the colonisation resistance of the H2O2producing lactobacilli, and through the introduction of
enteric gram-negative bacteria, but equally, that even
protected intercourse is associated with a significant
increase of enteric bacteria in the vagina. These
mechanisms therefore suggest that BV may behave as a
sexually enhanced disease rather than an (exclusively)
sexually transmitted infection. A critical factor - as outlined above - thereby presumably is the frequency of
intercourse as has been shown for BV [95] and for urinary tract infection [108,109], possibly by not granting
the vaginal ecosystem to restore after a coital act.
Finally, it may be concluded that at present, there is
little evidence in support of some kind of male-tofemale sexual transmission of BV-associated pathogens.
It may be acknowledged however that this transmission
route cannot be ruled out based on the available evidence. First, with the surge of molecular studies of the
vaginal microflora, a whole new series of previously
unknown bacteria has been identified with bacterial
vaginosis [110,111] and it is not known whether these
species might be transferred through sexual contact and
whether these may act as BV-inducing micro-organisms.
Secondly, there are some epidemiological data that cannot be explained solely by the sexually enhanced disease
model, in particular the observation in the Rakai study
[62] that male circumcision is strongly protective against
BV acquisition, possibly pointing at the presence of BVassociated bacteria on the prepuce, as recently corroborated by Swidsinski et al [26].
In summary, while there is inconclusive evidence in
support of male-to-female sexual transmission, we propose that the strong association between sexual behaviour - and level of sexual activity in particular - may be
explained by an alternative pathogenetic model, which
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implies that BV might behave as a sexually enhanced
disease rather than a sexually transmitted infection. This
model is in principle consistent with most epidemiological observations cited in this review.

Summary
• G. vaginalis carriage and BV occurs rarely with
children, but is common among adolescent, even
sexually non-experienced girls, contradicting that
sexual transmission a is necessary prerequisite to
disease acquisition.
• G. vaginalis carriage is enhanced by penetrative
sexual contact but also by non-penetrative digitogenital contact and oral sex, again indicating that
sex per se, but not necessarily coital transmission is
involved.
• Several observations also point at female-to-male
rather than at male-to-female transmission of G.
vaginalis, presumably explaining high concordance
rates of G. vaginalis carriage among couples. Male
antibiotic treatment has not been found to protect
against BV, condom use is slightly protective,
whereas male circumcision might protect against BV.
• BV is also common among women-who-have-sexwith-women and this relates at least in part to noncoital sexual behaviours.
• Though male-to-female transmission cannot be
ruled out, overall there is little evidence that BV acts
as an STD. Rather, BV may be considered a sexually
enhanced disease, with frequency of intercourse
being a critical factor.
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